home.social

#endometrialcancer — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #endometrialcancer, aggregated by home.social.

fetched live
  1. Arizona sues L’Oréal, claims hair relaxer chemicals raise women’s cancer risk

    TUCSON, Ariz. (13 News) – Arizona Attorney General Kris Mayes has filed a consumer fraud lawsuit against L’Oréal…
    #France #FR #Europe #EU #L'Oréal #Arizona #attorneygeneral #blackwomen #chemicalhairrelaxer #EndometrialCancer #krismayes #l'oreal #OvarianCancer #safety #softsheen-carson #UterineCancer
    europesays.com/france/86988/

  2. Immunotherapy shows potential for treating rising gynecological tumors

    Gynecological tumors, including cervical cancer (CC), endometrial cancer (EC), and ovarian cancer (OC), represent a significant global health…
    #NewsBeep #News #Health #Angiogenesis #Antibodies #Antibody #AU #Australia #Cancer #Cell #cervicalcancer #Drugs #Efficacy #endometrialcancer #GlobalHealth #Immunotherapy #medicine #mortality #OvarianCancer #PD-L1 #research #therapy #Tumor
    newsbeep.com/au/876510/

  3. L’Oreal Execs To Face More Questions Over Dark and Lovely, Hair Relaxer Cancer Risks

    In Pennsylvania state court, a group of hair relaxer lawsuits are consolidated for coordinated pretrial proceedings as part…
    #France #FR #Europe #EU #L'Oréal #Asbestos #BabyPowder #cancer #EndocrineDisruptors #EndometrialCancer #HairRelaxer #HairStraighteners #l'oreal #OvarianCancer #Perm
    europesays.com/france/43526/

  4. BioNTech reports promising Phase II data for uterine cancer ADC

    Trastuzumab pamirtecan, an investigational HER2‑targeted antibody-drug conjugate developed by BioNTech and DualityBio, has met the primary efficacy endpoint…
    #Europe #EU #ADC #BioNTech #Clinicaltrials #DualityBIO #endometrialcancer #European #oncology #uterinecancer
    europesays.com/europe/11565/

  5. CT radiomics-based explainable machine learning model for accurate differentiation of malignant and benign endometrial tumors: a two-center study | BioMedical Engineering OnLine

    This study was conducted in accordance with the tenets of the Dec…
    #NewsBeep #News #Technology #Biomaterials #BiomedicalEngineeringandBioengineering #BiomedicalEngineering/Biotechnology #Biotechnology #CA #Canada #CT #Endometrialcancer #machinelearning #PersonalizedMedicine #Radiomics
    newsbeep.com/ca/261062/

  6. This One Type Of Cancer Is Increasing In All Women, But One Group Is Particularly At Risk

    When you think of the most common gynecological cancer, you probably don’t think of uterine cancer, but this…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Health #Blackwomen #cervicalcancer #EbonyHoskins #EndometrialCancer #GettyImages #Hoskins #ovariancancer #uterinecancer
    newsbeep.com/us/45651/

  7. DATE: March 28, 2025 at 08:00AM
    SOURCE: BioWorld MedTech

    Direct article link at end of text block below.

    Acrivon narrows focus for ACR-368 in #endometrialcancer

    t.co/UcBD8f1Kxj

    #medtech #Acrivon

    Here are any URLs found in the article text:

    t.co/UcBD8f1Kxj

    #medtech

    Articles can be found by scrolling down the page at bioworld.com/topics/85-bioworl .

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org
    .
    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
    .
    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com
    .
    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
    subscribe-article-digests.clin
    .
    READ ONLINE: read-the-rss-mega-archive.clin
    .
    It's primitive... but it works... mostly...
    .
    -------------------------------------------------

    #healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

  8. DATE: March 27, 2025 at 06:00PM
    SOURCE: BioWorld MedTech

    Direct article link at end of text block below.

    Acrivon narrows focus for ACR-368 in #endometrialcancer

    t.co/UcBD8f1cHL

    #medtech #Acrivon

    Here are any URLs found in the article text:

    t.co/UcBD8f1cHL

    #medtech

    Articles can be found by scrolling down the page at bioworld.com/topics/85-bioworl .

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org
    .
    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
    .
    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com
    .
    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
    subscribe-article-digests.clin
    .
    READ ONLINE: read-the-rss-mega-archive.clin
    .
    It's primitive... but it works... mostly...
    .
    -------------------------------------------------

    #healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech

  9. AstraZeneca’s Truqap flops in phase III triple-negative breast cancer trial—Merck's Keytruda snags 40th US indication, leaps ahead of GSK with broad endometrial cancer approval —Roche partners with RNA editing biotech Ascidian—bit.ly/w28kSd #astrazeneca #breastcancer #clinicaltrials #endometrialcancer #merck #fda #rna #roche #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  10. Keytruda strikes out again in endometrial cancer with phase III flop—Novo inks $600M deal with Metaphore to develop next-gen obesity drugs —Takeda Pharma to restructure after annual profit slump --bit.ly/w28kSd #merck #keytruda #endometrialcancer #clinicaltrials #novonordisk #obesity #drugdevelopment #takeda #restructuring #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  11. In historic decision, FDA approves a CRISPR-based medicine for treatment of sickle cell disease-- FTC warns pharma companies on excessive drug patenting --Merck-Eisai's endometrial cancer therapy combo fails first-line treatment trial --bit.ly/w28kSd #fda #crispr #sicklecelldisease #ftc #patents #merck #eisai #endometrialcancer #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  12. Pfizer plans to shutter New Jersey campus, discloses layoffs amid $3.5B cost-cutting drive-- Bluebird bio to sell sickle cell FDA voucher for $103 mln if therapy approved --GSK's Jemperli prolongs life in endometrial cancer trial-- See more on our front page news bit.ly/w28kSd #pfizer #layoffs #newjersey #bluebirdbio #fda #sicklecelldisease #gsk #clinicaltrials #endometrialcancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  13. Next #TumorBoardTuesday 🧵 you may have missed

    ⏪ Rewind ⏪ to our fabulous fireside chat featuring a brief discussion on safety & management of #EndometrialCancer with @DrMMurphy @drteplinsky

    Sit back & listen while grabbing a bite to eat.
    #gyncsm
    ---
    RT @TumorBoardTues
    💥#EndometrialCancer TKI/IO safety data & AE mgmt webinar 💥┈┈┈ w @DrMMurphy & @drteplinsky ┈┈┈🔹#CME info 👉 bit.ly/3Vqtabi 👈 @BonumCe ┈┈┈🔸Supported by edu gra…
    twitter.com/TumorBoardTues/sta

  14. Speaking of catching up on #TumorBoardTuesday’s 𝗙𝗥𝗘𝗘 CME, we’ll add a couple of awesome threads 🧵 from the last week you may have missed.

    ⏪ Rewind ⏪ to last week’s excellent deep dive 🤿 tweetorial from @DrMMurphy @MeganLeigh127 on #EndometrialCancer
    ---
    RT @TumorBoardTues
    1/#OncTwitter #TumorBoardTuesday #MedTweetorial 🧵

    ✅#EndometrialCancer AE deep dive🤿
    🧪Trial results
    🔬Tox for TKI-ICI
    w @DrMMurphy @MeganLeigh127 & us!

    🆓#CME @…
    twitter.com/TumorBoardTues/sta

  15. 8/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

    #CME🔗bit.ly/3hYxu3R

    🔴#PostTest Q4️⃣
    During treatment w pembro + lenva, pt develops grade 3 HTN
    🔴What is the most effective mgmt strategy for this patient? (CS = corticosteroid)

  16. 6/#TumorBoardTuesday #BonumCE #GynCSM #EndometrialCancer
    #CME 🔗bit.ly/3hYxu3R

    🔴#PostTest Q 2️⃣
    📊During tx w pembro + lenva, pt develops grd 3 diarrhea
    🛑Lenva held
    💊Loperamide Rx
    Grade3️⃣diarrhea persists

    🔴Which is the appropriate next step for this pt?

  17. 3/#TumorBoardTuesday #gyncsm #OncTwitter

    🤔Missed the #EndometrialCancer #MedTweetorial earlier this wk?
    🤯Feeling left behind?

    Don't fret, it's here📍

    ---
    RT @BonumCe
    1/ #OncTwitter #TumorBoardTuesday
    ✅#EndometrialCancer #MedTweetorial🧵
    w @DrMMurphy @MeganLeigh127 @TumorBoardTues

    🧬Tx response
    🧪Trial results
    🔬Tox for TKI-ICI

    🆓#CME 🔗 bit.ly/3VBGJEJ
    Supported by educational grants from Eisai & @Merck
    twitter.com/BonumCe/status/161

  18. 3/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

    🟠Earn 🆓 #CME 🏆
    🟠#CME ℹ️🔗bit.ly/3YRDkog

    📸 Faculty disclosures & important CME info 👇

  19. 💥#EndometrialCancer TKI/IO safety data & AE mgmt webinar 💥┈┈┈ w @DrMMurphy & @drteplinsky ┈┈┈🔹#CME info 👉 bit.ly/3Vqtabi 👈 @BonumCe ┈┈┈🔸Supported by edu grants from Eisai & @Merck 🔹#TumorBoardTuesday #gyncsm #OncTwitter twitter.com/i/broadcasts/1yoJM

  20. 5...4...3...2...1...it's the final countdown
    ⏰30m warning
    🔥#EndometrialCancer #webinar w @DrMMurphy & @drteplinsky🔥

    👩‍🏫B4 we begin...👩🏻‍🏫
    ✅Answer #PreTest polls 👇
    🔁Retweet & tag colleagues

    #TumorBoardTuesday #OncTwitter #MedTwitter #GynCSM #gynonc

    ---
    RT @TumorBoardTues
    2/#TumorBoardTuesday #OncTwitter #GynCSM #gynonc
    #CME🔗bit.ly/3YRDkog

    🟢#PreTest Q 1️⃣
    📊Diarrhea, nausea, & vomiting are common GI toxicities associated w…
    twitter.com/TumorBoardTues/sta

  21. 5/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer
    #CME 🔗bit.ly/3YRDkog

    🟢#PreTest Q 4️⃣
    📊During treatment w pembro + lenva, pt develops grade 3 HTN
    🟢What is the most effective mgmt strategy for this patient? (CS = corticosteroid)

  22. 3/#TumorBoardTuesday #GynCSM #EndometrialCancer
    #CME🔗bit.ly/3YRDkog

    🟢#PreTest Q 2️⃣
    📊During tx w pembro + lenvatinib, pt develops grade 3 diarrhea
    🛑Lenva held
    💊Loperamide Rx
    Grade3️⃣diarrhea persists

    🟢What is the next step for this pt?
    (cs=corticosteroid)

  23. 1/#TumorBoardTuesday #OncTwitter

    🗓️TODAY🗓 w @DrMMurphy & @drteplinsky
    🎥#EndometrialCancer - Mnging TKI/IO AEs

    #CMEℹ️ bit.ly/3Vqtabi
    Support by edu grants from Eisai & @Merck

    🚨Be ready @ 8p ET/5p PT
    ✅Answer #PreTest👇
    🔁RT & tag 🩺

    🟢Where r u in your career?

  24. 27/

    🏔Conquer your next #EndometrialCancer🏔
    📍Here @TumorBoardTues
    🔥EC Fireside Chat🎥🔥
    🗓Thur, Jan 19 @ 8pm ET / 5pm PT

  25. 24/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc

    🏆#CME➡️ bit.ly/3jCyVFJ

    🔴Post Poll2️⃣
    🔴What is the most common grade 3 or higher toxicity associated w the combo of pembro & lenva in pts w #EndometrialCancer?

  26. 19/#TumorBoardTuesday #GynCSM #EndometrialCancer

    🚨Pembro-related immune tox🚨
    🔸Can affect any organ @ any time during/after tx
    🔹Can become severe/fatal if not promptly dx & tx
    🔸Typically reversible (excl. endocrine)
    🔹Managed w immunosuppressive tx - mainly corticosteroids

  27. 20/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

    🟢During treatment w pembro & lenva, pt develops frequent, loose, watery stools

    How could you quickly determine which drug is causing the diarrhea?

  28. 18/#TumorBoardTuesday #EndometrialCancer

    🤔Pre-empt tox w reduced lenva starting▶️dose?

    Retro analysis 70 pts: 20mg vs lower dose (mostly 14mg)
    📈# dose reductions &📉 time to tox @ 20mg
    ORR, PFS, & OS did NOT differ significantly w lower dose

    ✳️Need prospective data✳️

  29. 17/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

    45.6% pts ≥2 ⬇️lenva dose#KEYNOTE775
    🔸Often need new 30d dose pack b4 finishing current supply

    🆕Eisai dose exchange program - cover all indicated dose⬇️🔗bit.ly/3gYHvOd

  30. 16/#TumorBoardTuesday #BonumCE #OncTwitter #gyncsm #gynonc #EndometrialCancer

    💊 Lenva dose mods = dose reduce⬇️or withhold🛑for more severe tox

    Recommended lenva starting ▶️dose adv EC: 20mg QD
    🥇1st dose⬇️14mg
    🥈2nd dose⬇️10mg
    🥉3rd dose⬇️8mg

  31. 15/#TumorBoardTuesday #BonumCE #OncTwitter #gyncsm #gynonc #EndometrialCancer

    🟢During tx w/ pembro-lenva, a pt develops grade 3 HTN requiring reduction in lenva. Starting dose of lenva was 20mg.

    Which dose is recommended for lenva now?

  32. 14/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer

    🚨VEGFR TKI-related class tox e.g. HTN, proteinuria
    🗓Typ occur 1st few wks tx
    💊Dose-dependent
    🧮Managed w dose mods & supportive care (e.g. anti-hypertensive)

  33. 12/#TumorBoardTuesday #GynCSM #gynonc #EndometrialCancer

    ✏️Lenva-pembro tox distinct from chemotx
    ✏️Safety profile of combo tx consistent w those of individual agents
    ✏️Most common any grade & grade 3+TRAE = HTN
    ✏️Shortest⏱to onset: HTN
    ✏️Later: hypothyroidism & weight loss⬇️

  34. CW: Cancer, illness, family member

    Looking for a dab of kindness here. Long story short. My mom’s cancer returned. She has stage 3 endometrial cancer, and it looks like it’s gonna be a chronic condition she’s going to have to manage. She has a good medical team, plus me, my dad, and my sister. It’s just hard news. If you’re a #cancersurvivor or a family member of one who’s been through this or going through it, I would love to hear about your experience. ♥️ #cancer #EndometrialCancer #caregiver

Share on Mastodon

Enter the server where you have an account.